Management of Severe Hyperglycemia in Diabetes
Initial Assessment and Treatment
- For a patient with severe hyperglycemia, immediately initiate basal insulin at 0.5 units/kg/day along with metformin, while simultaneously assessing for ketosis/ketoacidosis and symptomatic hyperglycemia, as recommended by the American Diabetes Association 1, 2, 3
- Check for ketosis/ketoacidosis immediately by measuring serum and urine ketones, as this severe hyperglycemia mandates urgent evaluation for metabolic derangement, according to the American Diabetes Association 1, 2, 3
- Assess for symptoms of marked hyperglycemia including polyuria, polydipsia, nocturia, and weight loss, which indicate need for immediate insulin therapy, as stated by the American Diabetes Association 1, 2, 3
Treatment Algorithm
- Initiate subcutaneous or intravenous insulin immediately to rapidly correct hyperglycemia and metabolic derangement in patients with ketosis/ketoacidosis, as recommended by the American Diabetes Association 1, 2, 3
- Start basal insulin at 0.5 units/kg/day (typically long-acting insulin glargine administered once daily at bedtime) in patients with marked hyperglycemia without acidosis, according to the American Diabetes Association 1, 2, 3
- Simultaneously initiate metformin 500 mg twice daily with meals if eGFR >30 mL/min, titrating to 1000 mg twice daily over 1-2 weeks, as recommended by the American Diabetes Association 1, 2, 6
Comprehensive Management Strategy
- Provide comprehensive diabetes self-management education and support that is culturally appropriate at the time of diagnosis, as recommended by the American Diabetes Association 1, 2
- Implement medical nutrition therapy emphasizing nutrient-dense, high-quality foods and decreased consumption of calorie-dense, nutrient-poor foods, particularly sugar-added beverages, according to the American Diabetes Association 1, 2
- Prescribe at least 150 minutes of moderate-intensity aerobic activity per week, as recommended by the American College of Sports Medicine and the American Diabetes Association 5
Monitoring Protocol
- Assess glycemic status every 3 months with HbA1c measurement, as recommended by the American Diabetes Association 1, 2
- Implement blood glucose monitoring individualized to the pharmacologic treatment, with multiple daily checks when on insulin, according to the American Diabetes Association 1, 2
- Offer real-time continuous glucose monitoring (CGM) or intermittently scanned CGM for patients on multiple daily injections who are capable of using the device safely, as recommended by the American Diabetes Association 1, 2
Treatment Escalation if Goals Not Met
- If glycemic targets are not met with metformin and basal insulin after 3 months, add a GLP-1 receptor agonist approved for type 2 diabetes, as recommended by the American Diabetes Association 1, 2, 3
- If still not at goal with metformin, GLP-1 receptor agonist, and basal insulin, transition to multiple daily injections with basal and premeal bolus insulins or insulin pump therapy, according to the American Diabetes Association 1, 2, 3
Long-Term Glycemic Targets
- Target HbA1c <7% (53 mmol/mol) for most patients once stabilized, as recommended by the American Diabetes Association 1, 2, 5
- More stringent targets (such as <6.5%) may be appropriate for selected patients with short duration of diabetes and lesser degrees of beta-cell dysfunction if achievable without significant hypoglycemia, according to the American Diabetes Association 1, 2
- Less stringent targets (such as <8%) may be appropriate for individuals with history of severe hypoglycemia or limited life expectancy, as recommended by the American Diabetes Association 7, 5